Pound for pound, GLP-1 medications do not cause more muscle loss than dieting alone
Start your intake Distinct Mechanisms: Why Two Different Pathways Appeal to Providers Semaglutide works primarily through GLP-1 receptor activation, increasing insulin secretion, slowing gastric emptying, and reducing appetite signaling in the brain
3 Cayuga Medical Center, Ithaca, New York, USA
When facial fat and muscle shrink quickly, the skin may look loose, deflated, or drawn instead of smooth and lifted
In Phase 3 studies: Participants without diabetes taking orforglipron lost approximately 9% to 10% of body weight over roughly 36 to 40 weeks Participants with type 2 diabetes generally lost around 7% to 8% By comparison, Wegovy's landmark STEP trials reported approximately 14.9% average weight loss over 68 weeks